Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Pfizer Inc.
IndexDJIA S&P500 P/E17.57 EPS (ttm)1.59 Insider Own0.02% Shs Outstand6.34B Perf Week-1.90%
Market Cap177.10B Forward P/E12.55 EPS next Y2.23 Insider Trans-3.06% Shs Float6.34B Perf Month-8.12%
Income10.37B PEG7.22 EPS next Q0.55 Inst Own71.80% Short Float0.95% Perf Quarter-8.40%
Sales50.33B P/S3.52 EPS this Y37.50% Inst Trans-0.10% Short Ratio2.48 Perf Half Y-9.11%
Book/sh12.03 P/B2.32 EPS next Y-0.71% ROA17.20% Target Price34.13 Perf Year-6.15%
Cash/sh5.37 P/C5.20 EPS next 5Y2.43% ROE38.70% 52W Range27.51 - 32.67 Perf YTD-7.24%
Dividend1.04 P/FCF16.58 EPS past 5Y6.80% ROI10.50% 52W High-14.50% Beta0.72
Dividend %3.72% Quick Ratio2.40 Sales past 5Y1.30% Gross Margin81.30% 52W Low1.53% ATR0.50
Employees77700 Current Ratio2.70 Sales Q/Q-1.50% Oper. Margin33.40% RSI (14)34.81 Volatility1.73% 1.65%
OptionableYes Debt/Eq0.49 EPS Q/Q-10.00% Profit Margin59.30% Rel Volume1.60 Prev Close27.83
ShortableYes LT Debt/Eq0.42 EarningsOct 28 BMO Payout22.50% Avg Volume24.16M Price27.93
Recom2.30 SMA20-4.20% SMA50-4.37% SMA200-7.16% Volume38,721,252 Change0.36%
02-Jul-13Downgrade Standpoint Research Hold → Sell $24
15-Apr-13Reiterated Barclays Equal Weight $25 → $32
30-Jan-13Reiterated UBS Buy $29 → $31
30-Jan-13Reiterated Argus Buy $28 → $32
22-Jan-13Reiterated Barclays Equal Weight $24 → $25
27-Nov-12Downgrade MKM Partners Buy → Neutral $29 → $25
05-Oct-12Reiterated MKM Partners Buy $27 → $29
01-Nov-11Downgrade Standpoint Research Buy → Hold
07-Oct-11Initiated MKM Partners Buy $20.50
14-Sep-11Downgrade Barclays Capital Overweight → Equal Weight $21 → $19
10-Aug-11Upgrade Argus Hold → Buy $21
05-Aug-11Upgrade Standpoint Research Hold → Buy $21
14-Mar-11Downgrade Standpoint Research Buy → Hold
03-Nov-10Downgrade Argus Buy → Hold
21-May-10Initiated Jefferies Buy $17.80
16-Dec-09Initiated UBS Buy
27-Apr-09Initiated Standpoint Research Buy $20
12-Feb-09Upgrade Leerink Swann Mkt Perform → Outperform
09-Feb-09Upgrade UBS Neutral → Buy
02-Feb-09Upgrade Credit Suisse Neutral → Outperform
20-Oct-14 05:14PM  Actavis Said to Compete With Sanofi for Omega Pharma Deal at Bloomberg
04:10PM  Amgen Sues Sanofi and Regeneron over PCSK9 Candidate Zacks
02:54PM  Why Pfizer (PFE) Stock Remains a 'Buy' at TheStreet at TheStreet
02:20PM  3 Stocks Reiterated As A Buy: PFE, MU, CELG at TheStreet
11:00AM  Dow Jones (DJIA) Today: Pfizer (PFE) Lower at TheStreet
09:00AM  ViiV Healthcare Expands Program to Reduce HIV Disparities in Southern U.S. PR Newswire
17-Oct-14 05:22PM  Pfizer's AstraZeneca pursuit knocked by Shire deal collapse at Financial Times
04:38PM  FDA Approves Abuse Deterrent Labeling for EMBEDA┬« (morphine sulfate and naltrexone hydrochloride) Extended-Release (ER) Capsules CII Business Wire
03:38PM  Pfizer Loses a Bet on Removing Serious Warnings From its Chantix Pill at The Wall Street Journal
02:00AM  [$$] Panel Votes to Keep Strong Warning on Smoking-Cessation Drug at The Wall Street Journal
16-Oct-14 10:23PM  Baiyunshan's "Golden Spear" Targets Sweet Spot with Viagra Clone at Barrons.com
05:58PM  [$$] Panel Votes to Keep Strong Warning on Smoking-Cessation Drug at The Wall Street Journal
04:45PM  FDA panel votes to keep severe warning on Pfizer anti-smoking drug Reuters
04:03PM  FDA votes to keep black box warning on Pfizer anti-smoking drug Reuters
03:13PM  The Best-Selling Biologic Drugs at Forbes
03:07PM  Baxter Q3 Beats As Hemophilia Drugs Fend Off Rivals at Investor's Business Daily
01:50PM  [video] S&P 500: When Will the Selling Stop? at Bloomberg
01:50AM  AbbVie recommends shareholders reject Shire deal Reuters
12:55AM  AbbVie recommends stockholders to reject Shire deal Reuters
15-Oct-14 01:11PM  Shire Falls, AbbVie Questioned On Buyout Backtrack at Investor's Business Daily
11:59AM  AbbVies U-Turn Shows Shire Deal Was Driven by Taxes at New York Times
11:51AM  Hedge funds bleed as AbbVie reconsiders Shire bid Reuters
06:00AM  Biotech's Builder: How The Pharma's Landlord Could Benefit From The Drug Boom at Forbes
05:05AM  Shire Urges AbbVie to Pursue Merger Despite New Inversion Rules at New York Times
14-Oct-14 06:57PM  FDA: little evidence to drop Chantix boxed warning AP
05:15PM  Pfizer's Breast Cancer Candidate Gets Priority Review Zacks
03:28PM  Taking Stock: Bloombergs Sherman on Scrapped M&A Deals at Bloomberg
12:08PM  FDA staff recommend Pfizer keep black box warning on anti-smoking drug Reuters
12:01PM  FDA Staff Does Not Recommend Removing Serious Chantix Warnings at The Wall Street Journal
10:16AM  Ireland's Double Irish faces its demise at Financial Times
09:10AM  FDA staff wants Pfizer to keep black box warning on anti-smoking drug Reuters
13-Oct-14 06:00PM  Your first trade for Tuesday at CNBC
05:05PM  Iliad Joins Ranks of Acquirers That Bit the Dust in 2014 at Bloomberg
01:59PM  Alnylam Drug Scores Against Rare Nerve Disease at Investor's Business Daily
01:55PM  Steris makes UK tax leap with $1.9bn Synergy inversion deal at Financial Times
12:58PM  Renewed merger hopes boost AstraZeneca at Financial Times
12:58PM  [video] FMHR Final Trade: NFLX, PFE & more at CNBC
08:41AM  [$$] Pfizer Breast Cancer Treatment Gets Priority Review at The Wall Street Journal
08:00AM  Pfizer Announces FDA Acceptance Of Palbociclib New Drug Application With Priority Review Business Wire
10-Oct-14 08:00AM  Pfizer to Present New Data Evaluating Safety, Tolerability and Immunogenicity of its Investigational Staphylococcus aureus Vaccine Candidate at IDWeek 2014 Business Wire
09-Oct-14 06:25PM  Cramer: Activists are picking on the wrong chiefs at CNBC
08-Oct-14 04:28PM  Safety advocates seek stronger warnings on Chantix AP
03:28PM  Why Large Stocks Can Continue to Beat Smalland Why That's Not Bad News at Barrons.com
12:12PM  Up in Smoke? Consumer Groups Want Tougher Warnings for Pfizer's Chantix at The Wall Street Journal
08:30AM  Pfizer and Breast Cancer Leaders Join Together to Increase Understanding and Dispel Myths about Metastatic Breast Cancer Business Wire
08:00AM  Pfizer To Present Safety And Immunogenicity Data From A Phase 2 Study Of Its Investigational Meningococcal Group B Vaccine, Bivalent rLP2086, Co-Administered With A Licensed Human Papillomavirus Vaccine Business Wire
07-Oct-14 06:33PM  Actavis Finds Rx To Grow On Busy Drugmaker M&A Scene at Investor's Business Daily
04:39PM  Future of genetic testing CNBC
06-Oct-14 04:55PM  ARIAD Gets Breakthrough Therapy Designation for AP26113 Zacks
10:58AM  Actavis Expands Antibiotics Presence With Durata Buy at Investor's Business Daily
07:45AM  New Viagra TV Ad Should Be Dropped at Forbes
07:30AM  AstraZeneca heart drug gets preferred status in U.S. Reuters
01-Oct-14 04:20PM  Actavis in Patent Infringement Lawsuit for Purdue's Butrans Zacks
03:30PM  AbbVie Announces Positive Results on Oncology Candidate Zacks
09:04AM  Europe Buyers Cross Atlantic in $87 Billion U.S. Deal Spree Bloomberg
08:00AM  Portola Pharmaceuticals Announces Phase 3 ANNEXA(TM)-A Study of Andexanet Alfa and Eliquis (Apixaban) Met Primary and Secondary Endpoints With High Statistical Significance GlobeNewswire
30-Sep-14 06:44PM  European Buyers Cross Atlantic in $87 Billion U.S. Deal Spree Bloomberg
02:00PM  Drug, Device Companies Paid $3.5 Billion to U.S. Doctors Bloomberg
08:29AM  [video] Viagra's New Ad Campaign to Target Women for First Time at TheStreet
05:02AM  Viagra ads target women for 1st time AP
29-Sep-14 08:00PM  Pfizer And Kyowa Hakko Kirin To Collaborate On Immuno-Oncology Combination Study Business Wire
02:16PM  Business events scheduled for Tuesday AP
12:55PM  Pfizer Inc. Stock Fails To Break Out: Is It Headed Back Down? Benzinga
11:14AM  Cancer drug stocks on the move amid striking data at CNBC
28-Sep-14 05:45AM  Why multinationals aren't adding U.S. jobs at USA TODAY
27-Sep-14 06:45AM  Pfizers Lung Cancer Drug Helps Patients With Gene Defect at Bloomberg
06:45AM  Pfizer drug effective in patients with rare lung cancer -study Reuters
26-Sep-14 05:17PM  [video] Stock Pops & Drops: AGIO, MO, PFE & MU at CNBC
03:20PM  Pfizer Acquires InnoPharma, Injectables Business to Benefit Zacks
02:37PM  Focusing Solely On Animal Health Sets Zoetis Apart at Investor's Business Daily
09:21AM  AbbVie Said to Weigh More Shire Financing After U.S. Rule at Bloomberg
09:01AM  GlycoMimetics Announces a Delay in the Initiation of the Phase 3 Trial With Rivipansel GlobeNewswire
07:30AM  Pain Therapeutics Expands Pipeline With FENROCK(TM), an Abuse-Deterrent Pain Patch GlobeNewswire
25-Sep-14 05:59PM  Fast Money Final Trade: PFE, DOW, VRTX & the dollar CNBC
05:59PM  [video] Fast Money Final Trade: PFE, DOW, VRTX & the dollar at CNBC
02:15PM  5 Defensive Stocks Largely Avoiding the Sell-Off at 24/7 Wall St.
08:00AM  Pfizer Completes Acquisition Of InnoPharma Business Wire
24-Sep-14 06:35PM  Asian Stock-Index Futures Advance as Euro Holds Declines at Bloomberg
05:42PM  New FDA label bolsters safety case for Chantix AP
04:21PM  [video] The Top Ten Stocks for Sept. 24 at Bloomberg
03:53PM  Taking Stock: Sherman, Eisenberg Discuss Tax Inversion at Bloomberg
03:52PM  Smoke This: Pfizer Wants Serious Warnings Removed From Chantix at The Wall Street Journal
12:47PM  [$$] Pfizer Held Takeover Talks With Actavis at The Wall Street Journal
10:16AM  [video] The Top Ten Stocks for Wednesday, September 24 at Bloomberg
09:01AM  Faber: Actavis pursues Salix CNBC
08:00AM  Pfizer, Actavis Rumor, Inversion Turn Attention to Pharma ETFs ETF Trends
04:56AM  [video] Pfizer Looks Outside U.S. Despite New Tax Rules at Bloomberg
03:07AM  Pfizer Seeking Inversions Shows Companies Unfazed by Lew Bloomberg
02:31AM  Pfizer explored deal with rival Actavis: Report at CNBC
12:01AM  Pfizer Pursuing Inversions Shows Companies Undeterred by Lew at Bloomberg
23-Sep-14 11:52PM  [$$] Pfizer Held Takeover Talks With Actavis at The Wall Street Journal
08:19PM  [video] Will Anything Stop Pfizer's Inversion Plans? at Bloomberg
07:00PM  [video] Pfizer eyed Actavis takeover: Report at CNBC
06:45PM  Pfizer Investor's Business Daily
06:06PM  Stocks Finish Lower Among Takeover Rumors at Investor's Business Daily
05:07PM  New tax rules from Treasury CNBC
05:07PM  [video] New tax rules from Treasury at CNBC
04:37PM  Pfizer Said to Have Approached Actavis About Takeover to Lower Tax Rate Bloomberg
04:19PM  Stocks fall amid global concerns; small caps hit again at CNBC
03:00PM  Stocks Fall To Session Lows; Vipshop Bucks The Trend at Investor's Business Daily
Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines, and various consumer healthcare products. The company's Primary Care segment offers prescription pharmaceutical products primarily prescribed by primary-care physicians for various therapeutic and disease areas comprising Alzheimer's disease, cardiovascular, erectile dysfunction, genitourinary, major depressive disorder, pain, respiratory, and smoking cessation. Its Specialty Care and Oncology segment provides prescription pharmaceutical products for anti-infectives, endocrine disorders, hemophilia, inflammation, ophthalmology, pulmonary arterial hypertension, specialty neuroscience, and vaccines, as well as oncology and oncology-related illnesses. The company's Established Products and Emerging Markets segment offers prescription pharmaceutical products that had lost patent protection or marketing exclusivity in certain countries and/or regions, as well as sold in emerging markets, including Asia, Latin America, the Middle East, Eastern Europe, Africa, Turkey, and Central Europe. Its Consumer Healthcare segment provides non-prescription products in a range of therapeutic categories, such as dietary supplements, pain management, respiratory, and personal care. The company also offers Lyrica, the Prevnar family of products, Enbrel, Celebrex, Lipitor, Viagra, Zyvox, Norvasc, Sutent, and the Premarin family of products; and consumer healthcare products under the Advil, Caltrate, Centrum, ChapStick, Emergen-C, Preparation H, and Robitussin brands. It serves wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, and grocery and convenience stores. It has strategic alliance with CliniWorks (Israel) Ltd. to develop population health management platform with advanced analytics and patient care capabilities. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
OLSON LAURIE JExecutive Vice PresidentJun 12Option Exercise26.2036,275950,40593,010Jun 13 12:29 PM
OLSON LAURIE JExecutive Vice PresidentJun 12Sale29.5336,2751,071,27856,735Jun 13 12:29 PM
YOUNG JOHN DGroup PresidentMar 17Sale31.389,000282,42099,647Mar 18 09:33 AM
PFIZER INC10% OwnerMar 12Buy11.00272,7272,999,9971,235,330Mar 14 03:27 PM
SUSMAN SALLYExecutive Vice PresidentMar 04Sale32.5967,5852,202,872173,637Mar 05 05:36 PM
Dolsten MikaelPresident R&DMar 04Sale32.5835,7891,165,929344,571Mar 05 05:36 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerMar 04Sale32.555,082165,419171,756Mar 05 05:37 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerMar 03Option Exercise26.2075,5001,978,100274,699Mar 05 05:37 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerMar 03Sale32.0297,8613,133,674176,838Mar 05 05:37 PM
READ IAN CChairman & CEOFeb 26Option Exercise12.70324,9324,126,6361,410,536Feb 28 04:52 PM
SUSMAN SALLYExecutive Vice PresidentFeb 26Option Exercise12.70130,8751,662,113312,499Feb 28 04:52 PM
YOUNG JOHN DGroup PresidentFeb 26Option Exercise12.7057,586731,342116,884Feb 28 04:52 PM
BOURLA ALBERTGroup PresidentFeb 26Option Exercise12.7021,482272,82192,447Feb 28 04:52 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 26Option Exercise12.7056,411716,420228,878Feb 28 04:52 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 26Option Exercise12.70324,9324,126,636615,673Feb 28 04:52 PM
HILL CHARLES HExecutive Vice PresidentFeb 26Option Exercise12.7034,731441,084104,046Feb 28 04:52 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 26Option Exercise12.7034,568439,014120,562Feb 28 04:52 PM
JOHNSON RADY AExecutive Vice PresidentFeb 26Option Exercise12.7029,695377,12740,480Feb 28 04:52 PM
MADDALUNA ANTHONY JExecutive Vice PresidentFeb 26Option Exercise12.7029,695377,12783,716Feb 28 04:52 PM
OLSON LAURIE JExecutive Vice PresidentFeb 26Option Exercise12.7031,772403,50468,167Feb 28 04:52 PM
PFIZER INC10% OwnerFeb 04Buy8.00227,2611,818,0881,794,803Feb 06 03:53 PM
DAMELIO FRANK AExecutive Vice PresidentJan 13Sale30.82131,8104,062,225356,451Jan 14 07:13 PM
DAMELIO FRANK AExecutive Vice PresidentJan 13Sale30.8628,190869,817328,261Jan 14 07:13 PM
MADDALUNA ANTHONY JExecutive Vice PresidentNov 14Option Exercise26.2092,0002,410,400152,447Nov 18 03:31 PM
MADDALUNA ANTHONY JExecutive Vice PresidentNov 14Sale32.1092,0002,953,06360,447Nov 18 03:31 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerNov 01Sale31.2010,000311,985174,841Nov 04 03:59 PM
READ IAN CChairman & CEOOct 28Option Exercise26.20338,0008,855,6001,412,267Oct 29 05:44 PM
READ IAN CChairman & CEOOct 28Sale30.57338,00010,331,3151,074,267Oct 29 05:44 PM